These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22477198)
1. Effects of cysteine on the pharmacokinetics of paclitaxel in rats. Lee YK; Han SY; Chin YW; Choi YH Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198 [TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats. Choi BC; Choi JS; Han HK Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758 [TBL] [Abstract][Full Text] [Related]
3. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats. Lee CK; Choi JS Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Jin J; Bi H; Hu J; Zhong G; Zhao L; Huang Z; Huang M Biopharm Drug Dispos; 2010 May; 31(4):264-8. PubMed ID: 20437465 [TBL] [Abstract][Full Text] [Related]
5. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats. Choi YH; Suh JH; Lee JH; Cho IH; Lee MG J Pharm Pharmacol; 2010 Aug; 62(8):1084-8. PubMed ID: 20663044 [TBL] [Abstract][Full Text] [Related]
6. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Li X; Choi JS Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149 [TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Li C; Li X; Choi JS Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats. Lee JH; Lee A; Oh JH; Lee YJ Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118 [TBL] [Abstract][Full Text] [Related]
9. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats. Park JH; Park JH; Hur HJ; Woo JS; Lee HJ Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604 [TBL] [Abstract][Full Text] [Related]
10. Cysteine effects on the pharmacokinetics of etoposide in protein-calorie malnutrition rats: increased gastrointestinal absorption by cysteine. Suh JH; Kang HE; Yoon IS; Yang SH; Kim SH; Lee HJ; Shim CK; Lee MG Xenobiotica; 2011 Oct; 41(10):885-94. PubMed ID: 21623701 [TBL] [Abstract][Full Text] [Related]
11. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X; Choi JS Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel. Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875 [TBL] [Abstract][Full Text] [Related]
13. Effects of cysteine on the pharmacokinetics of tamoxifen in rats with protein-calorie malnutrition. Lee YK; Yoon I; Lee MG; Choi YH Xenobiotica; 2012 Dec; 42(12):1225-34. PubMed ID: 23035955 [TBL] [Abstract][Full Text] [Related]
14. Effects of morin on the pharmacokinetics of etoposide in rats. Li X; Yun JK; Choi JS Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145 [TBL] [Abstract][Full Text] [Related]
15. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Zhang W; Tan TM; Lim LY Drug Metab Dispos; 2007 Jan; 35(1):110-5. PubMed ID: 17050652 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes. Choi YH; Lee MG Xenobiotica; 2012 May; 42(5):483-95. PubMed ID: 22416982 [TBL] [Abstract][Full Text] [Related]
17. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. Peng SX; Ritchie DM; Cousineau M; Danser E; Dewire R; Floden J J Pharm Sci; 2006 Sep; 95(9):1984-93. PubMed ID: 16850393 [TBL] [Abstract][Full Text] [Related]
18. Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats. Lai L; Hao H; Wang Q; Zheng C; Zhou F; Liu Y; Wang Y; Yu G; Kang A; Peng Y; Wang G; Chen X Drug Metab Dispos; 2009 Dec; 37(12):2399-407. PubMed ID: 19741040 [TBL] [Abstract][Full Text] [Related]
19. Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors. Yang SH; Lee JH; Lee DY; Lee MG; Lyuk KC; Kim SH Arch Pharm Res; 2011 Oct; 34(10):1729-34. PubMed ID: 22076773 [TBL] [Abstract][Full Text] [Related]
20. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing. Gustafson DL; Long ME; Bradshaw EL; Merz AL; Kerzic PJ Cancer Chemother Pharmacol; 2005 Sep; 56(3):248-54. PubMed ID: 15856231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]